There has been no interest in 1102 and no non dilutive funding ....so Anp is yet to achieve anything as has been the case with this compound for the last 6-7 years.
Talk it up all you want but 1102 remains dead in the water and with the tech being superseded by next Gen antisense drugs it is very unlikely it will be anything more than a waste of time and money.
ANP Price at posting:
3.6¢ Sentiment: Buy Disclosure: Held
